SCHEMBL20095157

SCHEMBL20095157

C=C(N)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR4 O00206 1/20 0.43
▸ PTPN1 P18031 1/20 0.42
▸ IGF2R P11717 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ PRKCG P05129 1/20 0.40
▸ PRKCB P05771 1/20 0.40
▸ PRKCA P17252 1/20 0.40
▸ PRKCH P24723 1/20 0.40
▸ PRKCI P41743 1/20 0.40
▸ PRKCE Q02156 1/20 0.40
▸ PRKCQ Q04759 1/20 0.40
▸ PRKCZ Q05513 1/20 0.40
▸ PRKCD Q05655 1/20 0.40
▸ PRKD1 Q15139 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22452303 0.86 TLR4 (0.45) TLR4PTPN1L3MBTL1MEN1KMT2A
SCHEMBL19958457 0.80 TLR4 (0.50) TLR4PTPN1IGF2RCA2MEN1
SCHEMBL17853226 0.80 TLR4 (0.49) TLR4PTPN1L3MBTL1MEN1KMT2A
SCHEMBL19961526 0.80 TLR4 (0.49) TLR4PTPN1L3MBTL1MEN1KMT2A
SCHEMBL19901290 0.80 L3MBTL1 (0.48) TLR4PTPN1L3MBTL1MEN1KMT2A
SCHEMBL19958445 0.80 TLR4 (0.49) TLR4PTPN1L3MBTL1MEN1KMT2A
SCHEMBL16361991 0.80 TLR4 (0.49) TLR4PTPN1L3MBTL1MEN1KMT2A
SCHEMBL21944328 0.80 TLR4 (0.49) TLR4PTPN1L3MBTL1MEN1KMT2A
SCHEMBL21943693 0.80 TLR4 (0.49) TLR4PTPN1L3MBTL1MEN1KMT2A
SCHEMBL16351450 0.80 TLR4 (0.49) TLR4PTPN1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10273333-B2 Substituted polyesters by thiol-ene modification: rapid diversification for therapeutic protein stabilization THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-04-30 — — US disclosed
US-20180112034-A1 SUBSTITUTED POLYESTERS BY THIOL-ENE MODIFICATION: RAPID DIVERSIFICATION FOR THERAPEUTIC PROTEIN STABILIZATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2018-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180112034-A1 SUBSTITUTED POLYESTERS BY THIOL-ENE MODIFICATION: RAPID DIVERSIFICATION FOR THERAPEUTIC PROTEIN STABILIZATION TREH, MGAM, TRRAP TLR4 1263/4885PTPN1 2093/4885IGF2R 25/4885
US-10273333-B2 Substituted polyesters by thiol-ene modification: rapid diversification for therapeutic protein stabilization TREH, MGAM, TRRAP TLR4 1263/4885PTPN1 2093/4885IGF2R 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback